Delivery Order SPE2DB24D1205-SPE2DB25FCWNJ
- Not listed
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections with a ceiling value of $1,088.36. This contract, issued on May 23, 2025, represents a firm fixed price delivery order with an ultimate completion date of May 27, 2025 and carries no set-aside designation. The award was made through competitive procurement processes and serves as a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $9,965.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens on July 18, 2025, with a completion date of July 21, 2025. This non-set-aside delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion...
- The Defense Logistics Agency awarded a $3,109.35 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pen injections in 0.5 mL doses under a firm fixed-price contract. The order, valued at $2,038.95, was competitively awarded without set-aside provisions and is scheduled for completion by September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this delivery order. This award represents a child...
- The Defense Logistics Agency awarded a $3,771.95 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 mL pens on June 3, 2025, with completion expected by June 4, 2025. This non-set-aside contract utilizes firm fixed pricing and is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $11,495.12 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on May 27, 2025, with completion scheduled for May 28, 2025. This competitively awarded, firm fixed-price contract requires delivery to the company's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $11,125.48 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pens (tirzepatide injection), a diabetes medication, with completion targeted for September 15, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $26,703 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 19, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical prime vendor agreement running through...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWNJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens valued at $13,934.62 on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. As a prime vendor under the SPE2DX indefinite delivery vehicle, the company supplies a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Mounjaro, a diabetes management medication, reflects the company's ongoing role in supplying medications to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 5/6/25 |